Form 4: Okta COO Sells Shares After Option Exercise
Insider Transaction Report
Okta's President and COO, Eric Robert Kelleher, exercised stock options and subsequently sold a portion of his Class A Common Stock shares on October 1, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Eric Robert Kelleher, President and Chief Operating Officer of Okta, Inc. (OKTA), reported transactions on October 1, 2025.
- Kelleher exercised employee stock options to acquire 2,410 shares of Class B Common Stock at an exercise price of $8.97 per share.
- Concurrently, 2,410 shares of Class B Common Stock were converted into Class A Common Stock.
- Following the conversion, Kelleher sold a total of 2,410 shares of Class A Common Stock in two separate transactions.
- The first sale involved 1,610 shares at a weighted average price of $91.4495, with prices ranging from $90.99 to $91.75 per share.
- The second sale involved 800 shares at a weighted average price of $92.2925, with prices ranging from $92.06 to $92.68 per share.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Kelleher on April 15, 2025.
- After these transactions, Kelleher directly beneficially owns 9,174 shares of Class A Common Stock.
- Kelleher also holds various unexercised employee stock options and Restricted Stock Units (RSUs) with future vesting schedules.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an executive selling shares can sometimes be viewed negatively, the fact that these sales were pre-planned under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. The exercise of options also represents a realization of value from compensation.
Positives
- The exercise of stock options by the COO indicates the realization of value from previously granted equity compensation.
- The sales were conducted under a Rule 10b5-1 trading plan, which demonstrates pre-planning and adherence to insider trading regulations, reducing concerns about opportunistic selling.
Negatives
- The sale of shares by a high-ranking executive, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the executive's direct equity stake in the company.
Future Outlook
This Form 4 filing primarily reports past transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 15, 2025.
Industry Context
This filing is specific to an insider transaction at Okta and does not provide broader industry trends or competitive analysis. Insider transactions are a routine part of executive compensation and personal financial management across all industries.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The Reporting Person adopted a Rule 10b5-1 trading plan on April 15, 2025, which governed the reported share sales. | 2025-04-15 | The adoption of a 10b5-1 plan is a positive corporate governance practice, as it allows insiders to diversify their holdings while mitigating potential accusations of insider trading by pre-scheduling transactions. |
Stakeholder Impact
- Shareholders: The sale of shares by an executive slightly increases the float but is generally considered a routine event when conducted under a 10b5-1 plan, with minimal direct impact on share price or company fundamentals.
- Employees: The vesting of RSUs and exercise of options are part of the company's compensation structure, which can influence employee retention and motivation.
Next Steps
- Remaining shares underlying Restricted Stock Units (RSUs) will continue to vest in quarterly installments, subject to the Reporting Person's continuous employment with Okta.
Key Dates
| Date | Description |
|---|---|
| 2022-06-15 | Initial vesting date for a portion of 2,375 Restricted Stock Units (RSUs), with remaining shares vesting in 15 equal quarterly installments thereafter. |
| 2023-06-15 | Initial vesting date for a portion of 19,905 Restricted Stock Units (RSUs), with remaining shares vesting in 11 equal quarterly installments thereafter. |
| 2024-06-15 | Initial vesting date for a portion of 29,050 Restricted Stock Units (RSUs), with remaining shares vesting in 11 equal quarterly installments thereafter. |
| 2025-04-15 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 2025-06-15 | Initial vesting date for a portion of 52,799 Restricted Stock Units (RSUs), with remaining shares vesting in 11 equal quarterly installments thereafter. |
| 2025-10-01 | Date of reported transactions, including option exercise and share sales. |
| 2025-10-03 | Signature date of the reporting person's attorney-in-fact. |
| 2026-10-23 | Expiration date for Employee Stock Options (Right to Buy) with an exercise price of $8.97. |
| 2030-09-21 | Expiration date for Employee Stock Options (Right to Buy) with an exercise price of $211.86. |
| 2031-04-21 | Expiration date for Employee Stock Options (Right to Buy) with an exercise price of $274.96. |
| 2031-09-22 | Expiration date for Employee Stock Options (Right to Buy) with an exercise price of $255.38. |
Recommendation
holdThis Form 4 filing details routine insider transactions (option exercise and pre-planned sales) by a company executive. It does not contain information that fundamentally alters the investment thesis for Okta. While insider selling can sometimes be a negative signal, the use of a 10b5-1 plan indicates these were scheduled transactions, not reactive ones based on new material non-public information. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as it provides no new fundamental reason to buy or sell the stock.
Keywords
Okta, OKTA, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, 10b5-1 Plan, Executive Compensation, Share Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.